Craneware plc
22 September 2026
Craneware plc
(“Craneware” or the “Company” or the “Group”)
Purchase of Shares by Director
22 September 2026 - Craneware (AIM: CRW.L), a leader in healthcare financial performance solutions, announces that on 22 September 2026, Susan Nelson, an independent Non-Executive Director of the Company and Chair of the Company’s Audit Committee, purchased 1,408 Ordinary Shares of 1p each in the capital of the Company at a price of 1,054 pence per Ordinary Share.
Following the purchase of Ordinary Shares, Susan Nelson holds 1,408 Ordinary Shares in the capital of the Company, representing 0.004% of the Company’s issued share capital (excluding Ordinary Shares held in treasury).
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
- Details of the Restricted Person / person closely associated with him or her
a) NameSusan Nelson
- Reason for the notification
a) Position / statusNon-executive Director
b) Initial notification / AmendmentInitial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) NameCraneware plc
b) LEI213800O2CTJ1YFXNXG05
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of
instrumentOrdinary shares of 1p each in the capital of Craneware plc
b) Identification codeISIN GB00B2425G68
c) Nature of the transactionPurchase of Ordinary Shares
d) Price(s) and volume(s)Volume(s) 1,408, Price(s) £10.54
e) Aggregated information:N/A (single transaction)
i. Aggregated volume-
ii. Price(s) -
f) Date of the transaction2026-09-22
g) Place of the transactionLondon Stock Exchange (AIMX)
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma Strategic Communications |
+44 (0)20 3405 0205 |
|
Caroline Forde, Louisa El-Ahwal |
craneware@almastrategic.com |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Virginia Bull, Arnav Kapoor |
|
|
|
|
|
Berenberg (JointBroker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Tom Ballard, Patrick Dolaghan, Ryan Mahnke |
|
About Craneware
For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in healthcare financial and operational transformation, delivering cutting-edge technologies that drive measurable impact. Our Trisus® cloud ecosystem unifies data, revenue intelligence, margin intelligence, and advanced analytics, enabling healthcare organizations to optimize performance, improve financial sustainability, and drive strategic growth. As a trusted Microsoft partner, we provide future-ready solutions-including the Best in KLAS Trisus Chargemaster - that simplify the complexities of healthcare finance and operations. What sets us apart is our unique combination of deep healthcare expertise and engineering excellence, positioning us as a strategic partner rather than just a technology provider. The Craneware Group empowers healthcare organizations to achieve sustainable financial success while delivering better outcomes for the communities they serve - today and in the future. Together, we are transforming the business of healthcare.
Learn more at www.thecranewaregroup.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.